Back to Agenda

Looking forward to this session? Share it!

Routine clinical trial transparency activities - disclosure of study protocol, publishing and posting of results, and access to anonymized individual participants study data efforts are not aimed at the participants and public due to the format and the comprehension level. Therefore the need for plain language summaries of results to better inform study participants and the general public.

This session will offer insight on the impact and opportunities that plain language summaries have brought about on medical writing activities, trial transparency operations, and most importantly as a facilitator towards improved patient engagement and centricity in clinical research.

Learning Objectives

  • Overview of current national and regional clinical trial transparency laws, regulations and requirements
  • Impact and advancement opportunities that plain language summaries have on medical writing activities and clinical trial transparency operations
  • Making plain language summaries consistent with aggregate/tabulated study results to facilitate improved patient engagement and centricity in clinical research
  • Practical examples of plain language and health communication strategies that can be applied across functions and teams